# Safety and Efficacy of Vilazodone in Major Depressive Disorder

> **NCT01473381** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 1162 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Vilazodone
- **DRUG:** Placebo to citalopram
- **DRUG:** Placebo to vilazodone
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT01473381
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 1162 (ACTUAL)
- **Last updated:** 2014-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473381, "Safety and Efficacy of Vilazodone in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01473381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*